New incident report
Incident Report Number: 2020-3426
Registrant Reference Number: 2020-US-010368
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: UNITED STATES
Prov / State: UNKNOWN
PMRA Registration No. PMRA Submission No. EPA Registration No. 2596-168
Product Name: Hartz UltraGuard Dual Action Topical Flea and Tick Prevention for Dogs
PMRA Registration No. PMRA Submission No. EPA Registration No. 2596-125
Product Name: Hartz UltraGuard Flea and Tick Spray for Dogs
Liquid
Yes
Unknown
Site: Animal / Usage sur un animal domestique
No
Animal's Owner
Dog / Chien
Yorkshire Terrier
1
Male
5
5
lbs
Skin
>8 hrs <= 24 hrs / >8 h <= 24 h
>8 hrs <=24 hrs / > 8 h < = 24 h
System
Persisted until death
No
No
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 03-May-2020, a 5 year old, 5 pound, neutered, male, Yorkshire Terrier dog, in unknown condition, with no known concomitant medical condition, was administered 1 application of Hartz UltraGuard Dual Action Topical Flea and Tick Prevention for Dogs and Puppies 5-14lb (Etofenprox / N-Octyl-Bicycloheptene Dicarboximide (MGK-264) / Piperonyl Butoxide / Pyriproxifen) via the topical route by the animal owner. Approximately three hours later, the dog was also administered 1 application of Hartz UltraGuard Flea and Tick Spray for Dogs 16oz (Tetrachlorvinphos) via the topical route by the animal owner. This is an extra label use as the products are not intended to be used simultaneously. On 04-May-2020, the dog was found dead and was buried. The dog had not been evaluated by a veterinarian, no treatment had been performed and no necropsy had been performed.
Death
Assessment: Both products are considered to have a wide margin of safety in dogs. Although they are not intended to be applied simultaneously, severe signs, including sudden death are not expected. Other causes should be considered including underlying disease, unknown trauma, or other unknown exposures. No diagnostics including necropsy occurred so the cause of death is unknown. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.